Acasti Announces Third Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Acasti Pharma (ACST) Swings to Q3 Profit
January 13, 2015 5:11 PM ESTAcasti Pharma (NASDAQ: ACST) reported Q3 EPS of $0.03, versus ($0.05) reported last year. Revenue for the quarter came in at $29 million, versus $28 million reported last year.
For earnings history and earnings-related data on Acasti Pharma (ACST) click here.
... More